Drug Shortage Report for PMS-TADALAFIL
| Report ID | 67969 |
| Drug Identification Number | 02409429 |
| Brand name | PMS-TADALAFIL |
| Common or Proper name | TADALAFIL |
| Company Name | PHARMASCIENCE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | TADALAFIL |
| Strength(s) | 5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | G04BE |
| ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2018-11-28 |
| Estimated end date | 2020-01-06 |
| Actual end date | 2020-06-02 |
| Shortage status | Resolved |
| Updated date | 2020-06-03 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2020-06-03 | French | Compare |
| v7 | 2020-06-03 | English | Compare |
| v6 | 2019-06-28 | French | Compare |
| v5 | 2019-06-28 | English | Compare |
| v4 | 2019-01-16 | French | Compare |
| v3 | 2019-01-16 | English | Compare |
| v2 | 2018-11-29 | French | Compare |
| v1 | 2018-11-29 | English | Compare |
Showing 1 to 8 of 8